Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …

IRF5, a nucleoplasm shuttling protein, is a pivotal transcription factor regulating immune
system activity. It's well known that immunosuppression is involved in the development of …

Purpose The interferon regulatory factor 2 (IRF-2) acted as a tumor suppressor. We
inspected IRF-2 as a predictor of prognosis in gastric cancer (GC) patients and tried to find …

Interferon regulatory factor 6 (IRF6) acts as a tumor suppressor and controls cell
differentiation in ectodermal and craniofacial tissues by regulating expression of target …

Interleukin enhancer‑binding factor 3 (ILF3) may function as a transcriptional coactivator and
has been reported to be involved in tumor proliferation and metastasis; however, its role and …

Background/Aims: Interferon regulatory factor 1 (IRF-1) has been shown to function as a
transcriptional activator or repressor of a variety of target genes. However, its upstream, non …

IRX1 is originally characterized as a tumor suppressor gene of gastric cancer (GC) by our
group based on serially original studies. However, the molecular regulatory mechanisms of …

Abstract Interferon regulatory factor 2 (IRF-2) is known to play a pivotal role in the
development and progression of several malignancies. As a crucial member of interferon …

Interferon regulatory factor 2 binding protein 2 (IRF2BP2) is a transcriptional repressor
involved in regulating gene expression and other biological processes, including …

Simple Summary Colorectal cancer (CRC) is the second most common cause of cancer-
related death worldwide. While the exact causes and prognosis of CRC are complex …